Logo Intervacc
  • THE COMPANY
    • Operations
    • Strangvac®
    • Piggivac™
    • Management
    • The Board
    • Technology
    • Scientific publications
    • Patents
    • Our partners
  • FOR VETERINARIANS
    • The Product range
    • The Laboratory
    • Product guidance
    • Suppliers & Logistics
  • FOR INVESTORS
    • Few words from the CEO
    • The Market
    • Project portfolio
    • Press releases
    • Financial calendar
    • Financial reports
    • The Share
    • Shareholder list
    • Articles of Association
    • Prospectus & Company description
    • Certified Adviser
  • CURRENT
    • The Agenda
    • News briefs
U


SV

3

EN

Logo Intervacc
U


SV

3

EN

  • THE COMPANY
    • Operations
    • Strangvac®
    • Piggivac™
    • Management
    • The Board
    • Technology
    • Scientific publications
    • Patents
    • Our partners
  • FOR VETERINARIANS
    • The Product range
    • The Laboratory
    • Product guidance
    • Suppliers & Logistics
  • FOR INVESTORS
    • Few words from the CEO
    • The Market
    • Project portfolio
    • Press releases
    • Financial calendar
    • Financial reports
    • The Share
    • Shareholder list
    • Articles of Association
    • Prospectus & Company description
    • Certified Adviser
  • CURRENT
    • The Agenda
    • News briefs
Logo Intervacc
U


SV

3

EN

  • THE COMPANY
    • Operations
    • Strangvac®
    • Piggivac™
    • Management
    • The Board
    • Technology
    • Scientific publications
    • Patents
    • Our partners
  • FOR VETERINARIANS
    • The Product range
    • The Laboratory
    • Product guidance
    • Suppliers & Logistics
  • FOR INVESTORS
    • Few words from the CEO
    • The Market
    • Project portfolio
    • Press releases
    • Financial calendar
    • Financial reports
    • The Share
    • Shareholder list
    • Articles of Association
    • Prospectus & Company description
    • Certified Adviser
  • CURRENT
    • The Agenda
    • News briefs

Intervacc submits Type II variation to EMA seeking 12-month duration of immunity for Strangvac

by Developer Intevacc | 30 Jul, 2026 | Legal Press releases

Intervacc AB (publ) today announces that it has submitted a Type II variation application to the European Medicines Agency (EMA) for Strangvac®, the company’s innovative vaccine against strangles in horses. The application seeks to extend the stated duration of...

Intervacc makes first export of Strangvac to New Zealand under Special Circumstances Permit

by Developer Intevacc | 29 Jul, 2026 | Legal Press releases

Intervacc AB (publ) today announces that Strangvac®, the company’s innovative vaccine against strangles in horses, has been approved for import into New Zealand under a Special Circumstances Permit. The approval follows a request from the New Zealand Equine Health...
Sida 2 av 2« Föregående 12

Kontaktperson

Intervaccs VD Carl-Johan Dalsgard besvarar gärna frågor beträffande bolaget.

carl-johan.dalsgaard@intervacc.se
08-120 10 600

Contact

Please contact our CEO Carl-Johan Dalsgaard if you have questions regarding Intervacc

carl-johan.dalsgaard@intervacc.se
+46-8-120 10 600

Arkiv

Archives

RSS feed: Smittinfo – Svensk Travsport Smittinfo – Svensk Travsport

Nyhetstjänster

Cision News

DNB Carnegie

© 2026 Intervacc AB | Västertorpsvägen 135 B, SE-129 44 Hägersten | Phone: +46 (0)8-120 10 600 | Email: info@intervacc.se

Legal Disclaimer | Privacy & Integrity Policy

CONTACT US

IR Contact

Veterinary Contact

Media Contact

Intervacc
Cookie settings

We use cookies to ensure the website functions and to better understand how it is used. Some cookies are also used by third-party services, such as Google Analytics and YouTube. You choose which cookies you wish to approve and can change your choices at any time.

Functional Always active
These cookies are necessary for the website to function correctly and cannot be disabled.
Preferences
Technical storage or access is necessary for the legitimate purpose of storing preferences not requested by the subscriber or user.
Statistics
Technical storage or access used exclusively for statistical purposes. These cookies help us understand how the website is used, such as which pages are visited, so that we can improve the website.
Marketing
These cookies may be used to track visitors and display relevant content or marketing on the website and other platforms.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
Customize
  • {title}
  • {title}
  • {title}

The content on this website is intended solely for veterinarians and other animal health professionals.

By using this website, you confirm that the above applies to you.